U.S. Venture Partners


U.S. Venture Partners (USVP) is a venture capital firm that invests across multiple technology and life-sciences sectors. The provided content documents USVP portfolio activity and news (fundraises, product announcements, rebrands and industry recognitions) in areas including cybersecurity, marketing automation, fintech (401k), biotech/therapeutics, adtech/location intelligence and mobile/OTT. USVP also publishes portfolio company news and maintains an advisor network referenced on its site.


Services

Equity funding across early and growth stages

Provides capital to portfolio companies at multiple stages, as evidenced by coverage of Series A and Series B rounds and larger growth financings.

Strategic introductions / partnership facilitation

Facilitates strategic relationships for portfolio companies; example: Arkose Labs announced a strategic investment from PayPal.

Advisor network access

Maintains and promotes an advisor network (advisors listed include Irwin Federman, Mike Maher, Phil Young in the provided content).

Portfolio news and communications support (hosted news pages)

Publishes and aggregates portfolio company news on the USVP site (fundraises, product releases, awards and rebrands).


Portfolio

Multiple news items: new funding to accelerate growth marketing automation platform; product bundle for Microsoft Dynamics; named to Deloitte Technology Fast 500 for fifth consecutive year; year-end growth summary.

#Marketing automation / martech

401(k) provider that doubled valuation in a $55M fundraise (reported by USVP site).

#Fintech / retirement (401k)

Multiple financing events recorded on the USVP site: $6M Series A; $22M Series B led by M12; $70M led by SoftBank Vision Fund 2; strategic investment from PayPal.

#Cybersecurity / fraud prevention

Named to the Forbes 2017 Cloud 100 list (listed on USVP site).

#Sales acceleration / cloud SaaS

Rebranded from Cyberpion to IONIX; subsequent Series A extension reported (+$15M).

#Cybersecurity / attack surface management

Raised $38.5M in a round with involvement from Pfizer; VC total reported at $150M as of the article.

#Biotech / therapeutics

View All Portfolio Items

JOIN OUR MAILING LIST

Stay Connected with MTEC

Keep up with active and upcoming solicitations, MTEC news and other valuable information.